Across the universe of K-RAS mutations in non-small-cell-lung cancer.

Across the universe of K-RAS mutations in non-small-cell-lung cancer.

Item
http://www.wikidata.org/entity/Q38153826
Metabolic plasticity maintains proliferation in pyruvate dehydrogenase deficient cellsRole of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR)KRAS mutations affect prognosis of non-small-cell lung cancer patients treated with first-line platinum containing chemotherapyBase excision repair-mediated resistance to cisplatin in KRAS(G12C) mutant NSCLC cells.Value of KRAS as prognostic or predictive marker in NSCLC: results from the TAILOR trial.Different metabolic responses to PI3K inhibition in NSCLC cells harboring wild-type and G12C mutant KRAS.Targeting Novel but Less Common Driver Mutations and Chromosomal Translocations in Advanced Non-Small Cell Lung Cancer.Characterization of distinct types of KRAS mutation and its impact on first-line platinum-based chemotherapy in Chinese patients with advanced non-small cell lung cancer.Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib.
P2860

Across the universe of K-RAS mutations in non-small-cell-lung cancer.

Item
http://www.wikidata.org/entity/Q38153826
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Across the universe of K-RAS mutations in non-small-cell-lung cancer.
@en
type
label
Across the universe of K-RAS mutations in non-small-cell-lung cancer.
@en
prefLabel
Across the universe of K-RAS mutations in non-small-cell-lung cancer.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Across the universe of K-RAS mutations in non-small-cell-lung cancer
@en
P2093
P304
P31
P356
10.2174/13816128113196660761
P433
P478
P50
P577
P698